An exploration of nurse decision making when managing high risk medications in the intensive care unit.

Not Applicable

• Conditions: Vascular diseases; Haemodynamically Unstable Patients; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Cardiovascular - Other cardiovascular diseases; Public Health - Health service research

• Registration Number: ACTRN12619000989145
• Lead Sponsor: Eastern Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-11
• Last Update Posted: 22 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

Nurse inclusion criteria:
Nurses who are employed on a permanent full time or part time basis by the intensive care unit

Patient inclusion criteria:
Patients who have been admitted to the ICU
Patient has been allocated a nurse who has previously provided written consent to participate in either video or empirical data collection
Patients who are assessed by the ICU medical team as likely to need vasoactive support for the next 12 hours
Patients who have a functional arterial line in situ and
Patients who have a central venous catheter is in situ or insertion is imminent

Exclusion Criteria

Nurse exclusion criteria:
Nurses who have previously participated in this study
Nurses who do not have direct patient care responsibilities

Patient exclusion criteria:
Patients who are aged less than 18 years
Patients who will be out of the intensive care unit (ICU) for (i.e. for transport to Medical Imaging or
Operating Theatre) for the observation period
Patients who are assessed by the ICU treating team as unlikely to need vasoactive support for the four-hour data collection period.
Patients who have been transitioned to palliative care
Patients or their Medical Treatment Decision Makers are visibly distressed
The medical team or bedside nurse considers that it is an inappropriate time to approach the patient or Medical Treatment Decision Maker with information about the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified